Scinovex
articleTop 1% cited

Immunogenic death of colon cancer cells treated with oxaliplatin

Oncogene · 2009 · Vol. 29(4) · pp. 482–491
Antoine TesnièreF. SchlemmerValérie BoigeOliver KeppIsabelle MartinsFrançois GhiringhelliLaetitia AymericMichael MichaudLionel ApétohLudovic BaraultJean MendiboureJean‐Pierre PignonValérie JoostePeter Van EndertMichel DucreuxLaurence ZitvogelF PiardGuido Kroemer
Cancer Immunotherapy and BiomarkersDrug Transport and Resistance MechanismsImmunotherapy and Immune ResponsesBiologyImmunogenic cell deathCancer researchApoptosisImmune systemCancer cellMolecular biologyImmunologyCancerImmunotherapy

MeSH terms

OxaliplatinAgedAnimalsAntineoplastic AgentsCisplatinColonic NeoplasmsFemaleHumansMaleMice, Inbred BALB CMiddle AgedNeoplasm StagingNeoplasm TransplantationOrganoplatinum CompoundsPolymorphism, Genetic

Funding

  • World Health Organization
  • Fondation de France
Citations
1,118
FWCI
13.44
field-weighted impact
References
35
Percentile
99%
vs. same field & year
Citations per year
References
Cellular processing of platinum anticancer drugs
Nature Reviews Drug Discovery · 2005 · 3,720 citations
High mobility group box 1 protein interacts with multiple Toll-like receptors
American Journal of Physiology-Cell Physiology · 2005 · 933 citations
The resurgence of platinum-based cancer chemotherapy
Nature reviews. Cancer · 2007 · 4,639 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.